Skip to main content
All lobbying filings

NVG, LLC

NVG, LLC filed a Q4 report for ACCENDRA HEALTH INC. on January 20, 2026, reporting $80,000 in lobbying income.

Lobbying for ACCENDRA HEALTH INC. · Global healthcare solutions company.

All filings by NVG, LLC · Everything ACCENDRA HEALTH INC. has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues related to to the medical-surgical supply chain.

E-prescribing for home medical equipment. H.R.2902/S.1406 - SOAR Act of 2025. Issues related to diabetes management and durable medical equipment reimbursement channels. Issues related to Calendar Year 2026 Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program Updates and proposed DMEPOS Accreditation Requirements.

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem